Estándares SEA 2019 para el control global del riesgo cardiovascular

Mostaza J.M. ; Pintó X. ; Armario P. ; Masana L. ; Ascaso J.F. ; Valdivielso P. ; Arrobas Velilla T. ; Unidad de Lípidos Á.B. ; Calmarza P. ; Cebollada J. ; Civeira F. (Universidad de Zaragoza) ; Cuende Melero J.I. ; Salan M.E. ; Fernández Pardo J. ; Godoy D. ; Guijarro C. ; Jericó C. ; Laclaustra M. ; Rallo C.L. ; Millán J. ; Miranda J.L. ; Muñiz-Grijalvo O. ; Páramo J.A. ; Pascual V. ; Pedro-Botet J. ; Pérez-Martínez P. ; Plana N. ; Puzo J. (Universidad de Zaragoza) ; Real J.T. ; Ros E. ; Sánchez Chaparro M.Á. ; Vila L. ; en nombre de la Sociedad Española de Arteriosclerosis ; Miembros de la Sociedad Espanola de Arteriosclerosis

Resumen: One of the main goals of the Spanish Society of Arteriosclerosis is to contribute to a wider and greater knowledge of vascular disease, its prevention and treatment. Cardiovascular diseases are the leading cause of death in our country and also lead to a high degree of disability and health expenditure. Arteriosclerosis is a multifactorial disease, this is why its prevention requires a global approach that takes into account the different risk factors with which it is associated. Thus, this document summarizes the current level of knowledge and integrates recommendations and procedures to be followed for patients with established cardiovascular disease or high vascular risk. Specifically, this document reviews the main symptoms and signs to be evaluated during the clinical visit, the laboratory and imaging procedures to be routinely requested or those in special situations. It also includes the estimation of vascular risk, the diagnostic criteria of the different entities that are cardiovascular risk factors, and presents general and specific recommendations for the treatment of the different cardiovascular risk factors and their final objectives. Finally, the document includes aspects that are not often mentioned in the literature, such as the organisation of a vascular risk consultation.

Idioma: Español

DOI: 10.1016/j.arteri.2019.03.004

Año: 2019

Publicado en: Clinica e Investigacion en Arteriosclerosis 31, Sup. 1 (2019), 1-43
ISSN: 0214-9168

Factor impacto SCIMAGO: 0.277 - Pharmacology (medical) (Q3) - Cardiology and Cardiovascular Medicine (Q3)

Tipo y forma: Article (Published version)

Área (Departamento): Area Medicina (Dpto. Medicina, Psiqu. y Derm.)